3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, T-Cell
2
Uveal Melanoma
1
Neuroendocrine Tumors
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Follicular
1
Lymphoma, B-Cell
1
Leukemia-Lymphoma, Adult T-Cell
1
Immunoblastic Lymphadenopathy
1
Eye Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Neuroendocrine
1
Interventions
Fluorouracil
14
pembrolizumab
13
Paclitaxel
13
Oxaliplatin
13
Leucovorin
10
Carboplatin
9
Radiotherapy
8
Capecitabine
8
Trastuzumab
7
Nivolumab
7
Drug Therapy
7
Cisplatin
7
Radiation
6
Esophagectomy
6
Taxes
5
Specimen Handling
5
Surgical Procedures, Operative
4
Irinotecan
4
trastuzumab deruxtecan
3
tislelizumab
3
patritumab deruxtecan
3
Radiotherapy, Intensity-Modulated
3
Proton Therapy
3
Immunotherapy
3
Blood Specimen Collection
3
zanidatamab
2
ulixertinib
2
trastuzumab biosimilar HLX02
2
relatlimab
2
durvalumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Esophageal Neoplasms
×
belinostat
×
90 days
×
Clear all
No trials found.